Message-ID: <25696325.1075858652686.JavaMail.evans@thyme>
Date: Wed, 17 Oct 2001 07:58:39 -0700 (PDT)
From: gillian.johnson@enron.com
To: c..aucoin@enron.com, narsimha.misra@enron.com
Subject: MD Index Product PAT
Cc: richard.ring@enron.com, liqun.pan@enron.com, michele.raque@enron.com
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
Bcc: richard.ring@enron.com, liqun.pan@enron.com, michele.raque@enron.com
X-From: Johnson, Gillian </O=ENRON/OU=NA/CN=RECIPIENTS/CN=NOTESADDR/CN=3E222190-9C017A5E-86256A25-5553FD>
X-To: Aucoin, Berney C.  </O=ENRON/OU=NA/CN=RECIPIENTS/CN=BAUCOIN>, Misra, Narsimha </O=ENRON/OU=NA/CN=RECIPIENTS/CN=NMISRA>
X-cc: Ring, Richard </O=ENRON/OU=NA/CN=RECIPIENTS/CN=RRING>, Pan, Liqun </O=ENRON/OU=NA/CN=RECIPIENTS/CN=LPAN>, Raque, Michele </O=ENRON/OU=NA/CN=RECIPIENTS/CN=MRAQUE>
X-bcc: 
X-Folder: \RRING (Non-Privileged)\EESIISOPJM
X-Origin: Ring-R
X-FileName: RRING (Non-Privileged)1.pst

Can you please review this product approval template for the MD Index product?  We have been working with Michele and Liqun to get the product scoped out.  Of course, I will need your initials before Rogers will sign.

Thanks.

Gillian

  